-
Symbol
-
QCLS on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
8.48M shares
-
Security Ownership
-
74%
PharmaCyte Biotech, Inc. ownership in Q/C TECHNOLOGIES, INC. Common Stock, par value $0.001 per share (QCLS)
2025-11-18 - PharmaCyte Biotech, Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.48M shares of Q/C TECHNOLOGIES, INC. Common Stock, par value $0.001 per share (QCLS).
This represents 74% percent ownership of the company.